127 related articles for article (PubMed ID: 34577021)
1. Production of 6-l-[
Orlovskaya VV; Craig AS; Fedorova OS; Kuznetsova OF; Neumaier B; Krasikova RN; Zlatopolskiy BD
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577021
[TBL] [Abstract][Full Text] [Related]
2. A Practical Method for the Preparation of
Zarrad F; Zlatopolskiy BD; Krapf P; Zischler J; Neumaier B
Molecules; 2017 Dec; 22(12):. PubMed ID: 29244780
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
4. Automated synthesis and purification of [18F]fluoro-[di-deutero]methyl tosylate.
Beyerlein F; Piel M; Höhnemann S; Rösch F
J Labelled Comp Radiopharm; 2013 Jun; 56(7):360-3. PubMed ID: 24285440
[TBL] [Abstract][Full Text] [Related]
5. A Practical One-Pot Synthesis of Positron Emission Tomography (PET) Tracers via Nickel-Mediated Radiofluorination.
Zlatopolskiy BD; Zischler J; Urusova EA; Endepols H; Kordys E; Frauendorf H; Mottaghy FM; Neumaier B
ChemistryOpen; 2015 Aug; 4(4):457-62. PubMed ID: 26478840
[TBL] [Abstract][Full Text] [Related]
6. Automated production at the curie level of no-carrier-added 6-[(18)F]fluoro-L-dopa and 2-[(18)F]fluoro-L-tyrosine on a FASTlab synthesizer.
Lemaire C; Libert L; Franci X; Genon JL; Kuci S; Giacomelli F; Luxen A
J Labelled Comp Radiopharm; 2015 Jun; 58(7):281-90. PubMed ID: 26011311
[TBL] [Abstract][Full Text] [Related]
7. Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.
Füchtner F; Zessin J; Mäding P; Wüst F
Nuklearmedizin; 2008; 47(1):62-4. PubMed ID: 18278215
[TBL] [Abstract][Full Text] [Related]
8. A new precursor for the preparation of 6-[18F]Fluoro-L-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling.
VanBrocklin HF; Blagoev M; Hoepping A; O'Neil JP; Klose M; Schubiger PA; Ametamey S
Appl Radiat Isot; 2004 Dec; 61(6):1289-94. PubMed ID: 15388123
[TBL] [Abstract][Full Text] [Related]
9. The time course of metabolites in human plasma after 6-[(18)F]fluoro-l-m-tyrosine administration.
Wahl LM; Chen JJ; Thompson M; Chirakal R; Nahmias C
Eur J Nucl Med; 1999 Nov; 26(11):1407-12. PubMed ID: 10552081
[TBL] [Abstract][Full Text] [Related]
10. Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.
Mairinger S; Stanek J; Wanek T; Langer O; Kuntner C
Appl Radiat Isot; 2015 Oct; 104():124-7. PubMed ID: 26159661
[TBL] [Abstract][Full Text] [Related]
11. Experience of 6-l-[
Nanabala R; Pillai MRA; Gopal B
Nucl Med Mol Imaging; 2022 Jun; 56(3):127-136. PubMed ID: 35607634
[TBL] [Abstract][Full Text] [Related]
12. Production at the Curie level of no-carrier-added 6-18F-fluoro-L-dopa.
Libert LC; Franci X; Plenevaux AR; Ooi T; Maruoka K; Luxen AJ; Lemaire CF
J Nucl Med; 2013 Jul; 54(7):1154-61. PubMed ID: 23658219
[TBL] [Abstract][Full Text] [Related]
13. One-pot synthesis of high molar activity 6-[
Mossine AV; Tanzey SS; Brooks AF; Makaravage KJ; Ichiishi N; Miller JM; Henderson BD; Skaddan MB; Sanford MS; Scott PJH
Org Biomol Chem; 2019 Oct; 17(38):8701-8705. PubMed ID: 31536095
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
DeJesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
J Nucl Med; 1997 Apr; 38(4):630-6. PubMed ID: 9098215
[TBL] [Abstract][Full Text] [Related]
15. Fully automated one-pot synthesis of [18F]fluoromisonidazole.
Tang G; Wang M; Tang X; Gan M; Luo L
Nucl Med Biol; 2005 Jul; 32(5):553-8. PubMed ID: 15982586
[TBL] [Abstract][Full Text] [Related]
16. Automated synthesis of 4-[(18)F]fluoroanisole, [(18)F]DAA1106 and 4-[(18)F]FPhe using Cu-mediated radiofluorination under "minimalist" conditions.
Zischler J; Krapf P; Richarz R; Zlatopolskiy BD; Neumaier B
Appl Radiat Isot; 2016 Sep; 115():133-137. PubMed ID: 27372807
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide.
Kuhnast B; de Bruin B; Hinnen F; Tavitian B; Dollé F
Bioconjug Chem; 2004; 15(3):617-27. PubMed ID: 15149190
[TBL] [Abstract][Full Text] [Related]
18. Fully automated one-pot radiosynthesis of O-(2-[18F]fluoroethyl)-L-tyrosine on the TracerLab FX(FN) module.
Bourdier T; Greguric I; Roselt P; Jackson T; Faragalla J; Katsifis A
Nucl Med Biol; 2011 Jul; 38(5):645-51. PubMed ID: 21718939
[TBL] [Abstract][Full Text] [Related]
19. Aromatic L-amino acid decarboxylase (AAAD) inhibitors as carcinoid tumor-imaging agents: synthesis of 18F-labeled alpha-fluoromethyl-6-fluoro-m-tyrosine (FM-6-FmT).
Murali D; Flores LG; Roberts AD; Nickles RJ; DeJesus OT
Appl Radiat Isot; 2003 Oct; 59(4):237-43. PubMed ID: 14522231
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
